Cargando…
A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is still a menace to public wellbeing globally. However, the underlying molecular events influencing the carcinogenesis and prognosis of HNSCC are poorly known. METHODS: Gene expression profiles of The Cancer Genome Atlas (TCGA) HNSCC dataset...
Autores principales: | Mai, Zizhao, Chen, Huan, Huang, Mingshu, Zhao, Xinyuan, Cui, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810637/ https://www.ncbi.nlm.nih.gov/pubmed/35127477 http://dx.doi.org/10.3389/fonc.2021.770241 |
Ejemplares similares
-
Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020) -
The Prognostic Significance of Immune-Related Metabolic Enzyme MTHFD2 in Head and Neck Squamous Cell Carcinoma
por: Cui, Li, et al.
Publicado: (2020) -
Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021) -
The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma
por: Ming, Ruijie, et al.
Publicado: (2021) -
Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)